Altasciences Company Inc.
22
3
6
14
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 22 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
21%
3 of 14 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
SXC-2023 Cocaine Interaction Study
Role: collaborator
VK4-116 Phase I Study With Food-Effect
Role: collaborator
Phase I PK and Safety Study of Ondansetron Inhalation Powder
Role: collaborator
A Study of SPY001-001 in Healthy Volunteers
Role: collaborator
A Study of SPY003-207 in Healthy Volunteers
Role: collaborator
A Single-Dose, Randomized, Open-Label, 2-Way Crossover Study to Evaluate the Dose-Proportionality, Safety, and Tolerability of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) in Healthy Japanese and Chinese Subjects
Role: collaborator
Phase 1 Study of SBS-147 in Healthy Adults
Role: collaborator
A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease
Role: collaborator
Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience
Role: lead
A Study of SPY002-091 in Healthy Volunteers
Role: collaborator
Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients.
Role: collaborator
An Open-label DDI Study of Omaveloxolone in Healthy Subjects
Role: collaborator
TH1902 in Patients With Advanced Solid Tumors
Role: collaborator
A Study of SPY002-072 in Healthy Volunteers
Role: collaborator
Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
Role: collaborator
Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting Conditions
Role: collaborator
A Safety Study of AZD4041 in Healthy Participants
Role: collaborator
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
Role: collaborator
The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions
Role: collaborator
The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.
Role: collaborator